These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6469755)

  • 1. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misonidazole-glutathione conjugates in CHO cells.
    Varghese AJ; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1341-5. PubMed ID: 6540764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers.
    Koch CJ; Giandomenico AR; Iyengar CW
    Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
    Rasey JS; Krohn KA; Grunbaum Z; Conroy PJ; Bauer K; Sutherland RM
    Radiat Res; 1985 Apr; 102(1):76-85. PubMed ID: 3983371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA; Franko AJ; Koch CJ; Born JL
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a reactive metabolite of misonidazole in hypoxic mammalian cells.
    Varghese AJ; Whitmore GF
    Radiat Res; 1984 Feb; 97(2):262-71. PubMed ID: 6538047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B; Faddegon B; Skarsgard LD
    Radiat Res; 1984 Nov; 100(2):340-7. PubMed ID: 6494445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
    Born JL; Smith BR; Harper N; Koch CJ
    Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites.
    Franko AJ; Koch CJ
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1333-6. PubMed ID: 6469756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: quantitative differences found using the radiation sensitizing agent misonidazole or oxygen.
    Koch CJ; Stobbe CC; Bump EA
    Radiat Res; 1984 Apr; 98(1):141-53. PubMed ID: 6718689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic properties of hydroxylamino- and amino-misonidazole, possible metabolic products of misonidazole, in hypoxic HeLa S3 cells.
    Murayama C; Hori H; Mori T; Inayama S
    Gan; 1983 Oct; 74(5):693-8. PubMed ID: 6642142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased radiosensitivity of aerobic mammalian cells following pre-incubation with misonidazole in hypoxia.
    Michaels HB
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1271-4. PubMed ID: 6469749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ; Whitmore GF
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and chemical reduction products of misonidazole.
    Varghese AJ; Whitmore GF
    Chem Biol Interact; 1981 Aug; 36(2):141-51. PubMed ID: 7273240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC; Rauth AM
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
    Franko AJ; Chapman JD
    Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of misonidazole to EMt6 and V79 spheroids.
    Franko AJ; Chapman JD; Koch CJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):737-9. PubMed ID: 7107407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.